International Funding Schemes

Alzheimer's Drug Discovery Foundation (ADDF): Academic Applications for funding

Worldwide Cancer Research: Project Grant

Bill and Melinda Gates Foundation

Cancer Research UK: Grand Challenges

European Research Council (ERC)

Merck Group (Merck KGaA): Research Grants and Compound Challenge

Misk Foundation: Grand Challenges

Partnership for Clean Competition (PCC): Grant Program: Pre Applications

Susan G Komen: Career Catalyst Research (CCR) Grants 2018-19

US Department of Defense (DOD) Research Programs includingPeer Reviewed Alzheimer's Research Program and Epilepsy Research Program

Wellcome Trust

Back to calendar


Alzheimer's Drug Discovery Foundation (ADDF): Academic Applications for funding

Grant typeInternational Grant

Funding opportunity

Academic applications for funding

Scheme overview

The ADDF Academic Drug Discovery and Development Program seeks to create and support innovative translational research programs for Alzheimer's disease, related dementias and cognitive aging in academic medical centers and universities.
Biomarker development studies and innovative proof of concept pilot clinical trials of new approaches to treatment, prevention and early detection are also supported.

Grant proposals are accepted for:

  • Drug Discovery
  • Clinical Trials
  • Biomarkers
  • Prevention

Funding available

Academic grants average US $150,000 per year for up to two years, and the biotechnology grants average US $200,000-$300,000 per year for up to two years. Grant requests for clinical trials can be up to US $1.5 million.

Eligibility

The ADDF funds both academic institutions (including non-profit research centers) as well as for-profit biotechnology companies. International applications are welcome.
NOTE: All applications must commence with a Letter of Intent, submitted directly to the ADDF. A response should be received within 2 weeks of submission, and this will advise whether a full proposal is invited.

Opening date

February, May, August and November annually

External closing date:
Letter of Intent

11 October 2019

External closing dateInvited Full Application

8 November 2019

Compliance check (RIS/GPT)

Grant Partnerships Team

External source overview

ADDF website

Top 

Worldwide Cancer Research (formerly Association for International Cancer Research): Project Grant

Grant typeInternational Grant

Funding opportunity

Worldwide Cancer Research (formerly Association for International Cancer Research): Project Grant

Scheme overview

WCR's goal is to fund scientific research that may, in future, help reduce the incidence of cancer or improve cancer survival. They award project grants to support basic and translational research into the causes, mechanisms, diagnosis, treatment and prevention of cancer.

Basic studies into fundamental cellular processes, mechanisms and molecules are within the WCR funding remit if it is clear that the aim of the research is to improve the understanding of cancer biology. If an applicant proposes to study the normal functioning of cellular processes, mechanisms or molecules evidence supporting the relevance to cancer biology must be well laid out.

Funding available

(1-3 years duration) ~200,000 pounds

Eligibility

The Principal Investigator must have:

  • a PhD with at least three years post doctoral experience
  •  an employment contract for the duration of the funding within a recognised research institution (hospital, university, research institute)
  • Typically, AICR grants support one (sometimes two) salaried staff plus consumables
  • AICR does not award grants for infrastructure development or sample collection alone. However, grants may be awarded for a research project which involves some infrastructure development or sample collection as an essential prelude to the research.

Opening date

April 2020

Internal closing date

 

External closing date

 

Compliance check (RIS/GPT)

Grant Partnerships Team

External source overview

Worldwide Cancer Research

Top 

Bill and Melinda Gates Foundation: Grand Challenges in Global Health

Grant typeInternational Grant

Funding opportunity

Bill and Melinda Gates Foundation: Grand Challenges in Global Health

Scheme overview

The Bill and Melinda Gates Foundation has launched a new Grant Challenge.

The Foundation) is soliciting proposals to develop manufacturing platforms that can transform vaccine production economics and produce vaccines at a final finished goods production cost of â $0.15 per dose. To ensure the greatest impact in applying discoveries to reduce inequality, the vaccine must come from the below priority list (given in alphabetical order). These vaccines target diseases of great global burden and are among the most costly to produce with current technologies.

  • Human papillomavirus vaccine
  • Inactivated poliovirus vaccine
  • Measles-rubella vaccine
  • Pentavalent vaccine (diphtheria, tetanus, whole-cell pertussis, hepatitis B, Hib)
  • Pneumococcal vaccine
  • Rotavirus vaccine
Funding available

There is no funding limit or expectation for this Challenge round.

Eligibility

Grand Challenges is open to both foreign and domestic organizations, including non-profit organizations, for-profit companies, international organizations, government agencies and academic institutions.

Opening date

February 2020

Internal closing date

N/A

External closing date

April 2020

Compliance check (RIS/GPT)

N/A

External source overview

Bill and Melinda Gates Foundation

Top 

Bill and Melinda Gates Foundation: Grand Challenges Explorations

Grant typeInternational Grant

Funding opportunity

Bill and Melinda Gates Foundation: Grand Challenges Explorations - Round 22

Scheme overview

Grand Challenges Explorations, an initiative to encourage innovative and unconventional global health and development solutions, is now accepting grant proposals for its latest application round. The initiative uses an agile, accelerated grant-making process with short two-page applications and no preliminary data required. Applications are submitted online, and winning grants are chosen approximately 4 months from the submission deadline.

Two-page proposals are being accepted online on the following topics:

  • Application of Metagenomic Next Generation Sequencing to Detect and Identify Pathogens
  • New Approaches for Manufacturing Gut Microbial Biotherapeutics
  • Iincreasing Demand for Vaccination Services

Funding available

Initial grants will be US $100,000 each, and projects showing promise will have the opportunity to receive additional funding of up to US $1 million.

Eligibility

Applicants can be at any experience level; in any discipline; and from any organization, including colleges and universities, government laboratories, research institutions, non-profit organizations and for-profit companies.

Opening date

Opening throughout the year

Internal closing date

N/A

External closing date

 

Compliance check (RIS/GPT)

N/A

External source overview

Bill and Melinda Gates Foundation

Top  

Bill and Melinda Gates Foundation: Grand Challenge for Development: Round 8

Grant typeInternational Grant

Funding opportunity

Bill and Melinda Gates Foundation: Grand Challenge for Development - Round 8

Scheme overview

A Grand Challenge for Development has launched its seventh round for Saving Lives at Birth.

Funding available

Funding levels will correspond to the scope and scale of the innovation but generally be $US250,000 per seed project and validation project and $2M for transition awards.

Eligibility

Applicants can be at any experience level; in any discipline; and from any organization, including colleges and universities, government laboratories, research institutions, non-profit organizations and for-profit companies.

Opening date

January and July annually. 

Internal closing date

N/A

External closing date

 

Compliance check (RIS/GPT)

N/A

External source overview

Bill and Melinda Gates Foundation

Top 

Cancer Research UK: Grand Challenge

Grant typeInternational Grant

Funding opportunity

Cancer Research UK: Grand Challenge

Scheme overview

Cancer Research UK's Grand Challenge is the most ambitious cancer research initiative in the world: a series of £20m awards seeking international, multidisciplinary teams willing to take on the toughest challenges in cancer, and providing the freedom to try novel approaches, at scale. 

Cancer Research UK is asking the international research community to help us shape their next set of Grand Challenges. Share your idea for a Grand Challenge through their online form or run your own challenge-setting workshop at your institution.

Funding available

£20m in total funding

Eligibility

Applicants can be from any country, any discipline, any academic institution or commercial entity and at any career stage. 

Opening date

August 2019

Internal closing date

N/A

External closing date

15 November  2019

Compliance check (RIS/GPT)

N/A

External source overview

Cancer Research UK

Top

European Research Council (ERC): Starting Grants, Consolidator Grants and Advanced Grants

Grant typeInternational Grant

Funding opportunity

European Research Council (ERC): Grant Schemes

Scheme overview

The fundamental activity of the ERC is to provide attractive, long-term funding to support excellent investigators and their research teams to pursue ground-breaking, high-gain/ high-risk research.

The ERC provides funding opportunities for excellent scientists in all fields of research with approximately 1.8 billion euros in 2017.

The ERC annually launches calls for proposals in three funding schemes: Starting Grants, Consolidator Grants and Advanced Grants.

  • Starting Grants: for excellent young scientists of all nationalities.
  • Consolidator Grants: supports promising researchers who are at the beginning of an independent research career.
  • Advanced Grants: addresses excellent, established researchers with extensive research experience of more than 10 years.
  • Synergy Grants: outstanding intrinsic synergetic effect

Funding available

Starting Grants: maximum 1.5m euros over 5 years
Consolidator Grants: maximum 2m euros over 5 years
Advanced Grants: 2.5m euros over 5 years
Synergy Grants: 10m euros over 6 years

Eligibility

Starting Grant: PI shall have been awarded PhD >2 and <7 years (between 1 January 2010 to 1 January 2015) and have at least one important publication as main author or without participation from their PhD supervisor.

Consolidator Grants: PI shall have been awarded PhD >7 and <12 years (between 1 January 2005 and 31 December 2009) and have several important publications as main author or without participation from their PhD supervisor.

Advanced Grants: PI expected to have active track record of significant research achievements in the last 10 years. Together with at least 10 publications, research monographs, patents, invited presentations, research expeditions, international conferences and recognition etc.

Proof of Concept Grants: For ERC grantees to bridge the pag between research and marketable innovation.

A researcher may participate as PI or Co Investigator  in only one ERC frontier research project at any one time.

Opening date

Starting Grants: July 2019
Consolidator Grants: October 2019
Synergy Grants: open call
Advanced Grants: May 2020
Proof of Concept: June 2020

Internal closing date

Starting Grants: 2 October 2019
Synergy Grants: 22 October 2019
Advanced Grants: August 2020
Proof of Concept: 5 September 2019

External closing date

Starting Grants: 16 October 2019
Synergy Grants: 5 November 2019
Consolidator Grants: February 2020
Advanced Grants: August 2020
Proof of Concept: 19 September 2019

Compliance check (RIS/GPT)

DVRCI office

External source overview

ERC website

Top  

Merck: Research Grants and Compound Challenge

Grant typeInternational Grant

Funding opportunity

Merck: Research Grants and Compound Challenge

Scheme overview

This year Merck are celebrating their 350 year anniversary by offering multiple one-off research grants and monetary prizes for challenges. Merck are very keen that as many Australian and New Zealand researchers as possible have the opportunity to apply.

Merck is offering several Research Grants, in four areas: Healthy Lives/Drug Discovery, Materials & Solutions, Life Reimagined/Synthetic Biology and Digitalisation/Computing.

Merck is offering Research Challenges, in five areas: Protein Production, Innovative Analytics Technologies, Diabetes Prevention, Compound Synthesis, Next Game-changing Technology. 

Funding available

Grants up to €350,000 per year for 3 years. Challenges range from €3,000 to €30,000.

Eligibility

Refer to website 

Opening date

June 2019

Internal closing date

 

External closing date

 

Compliance check (RIS/GPT)

Contact Kerstin Holata for application support

External source overview

 Merck Group website

 

Misk Foundation: Grand Challenges

Grant typeInternational Grant

Funding opportunity

Misk Foundation: Grand Challenges

Scheme overview

Misk Grand Challenges is a collaboration between the Misk Foundation, a non-profit philanthropic foundation established by HRH Crown Prince Mohammad bin Salman to empower young people to succeed in the knowledge economy, and the Bill & Melinda Gates Foundation, which funds global health and development programs for the world’s poorest people.

Young people are growing up in a world changing faster and more fundamentally than ever before. A technology revolution is transforming the way we live, learn, work and contribute to our communities. Together, we can harness this change to build a better world of opportunity for the next generation.

Two Grand Challenges are Global Citizenship and Education.

Funding available

$US100,000

Eligibility

  • Proposed solutions should target Global Citizenship and Education for people under 30 years in addition to specific criteria mentioned in individual challenges.
  • Young people are encouraged to apply

Opening date

November 2019

Internal closing date

 

External closing date

 

Compliance check (RIS/GPT)

Advancement Services

External source overview

Misk Foundation website

 

Partnership for Clean Competition (PCC): Grant Program: Pre Applications

Grant typeInternational Grant

Funding opportunity

Partnership for Clean Competition (PCC): Grant Program: Pre Applications

Scheme overview

PCC-supported research contributes to a movement in addressing doping's root causes and ultimately decreasing the use of performance-enhancing drugs by all participants in all sports at all levels of play. With an emphasis on original work that focuses on improving existing analytical methods for detecting particular drugs, developing new analytical methods to test for substances not currently detectable, and discovering cost-effective approaches for testing widely abused substances across all levels of sport, the following areas of investigation reflect the PCC's current research priorities:

  • Developing methods of cost-effective testing to detect and deter the use of banned and illegal substances.
  • Developing testing protocols to detect designer substances used for doping purposes.
  • Improving existing analytical methods to detect particular drugs, ex. GH, IGF-1, EPO, hCG.
  • Developing analytical methods to detect performance enhancing drugs not currently detectable.
  • Longitudinal urinary excretion patterns, metabolism and dose-concentration.
  • Critical reviews to support interpretation of laboratory data.
  • Alternative specimens, (ex. oral fluid, dried blood/plasma spots) for testing.

Funding available

US$10,000 - US$400,000

Eligibility

Refer to PCC website

Opening date

August

Internal closing date

N/A

External closing date

1 March, 1 July, 1 November annually for pre applications. 1 April, 1 August, 1 December annually for full applications

Compliance check (RIS/BDU)

N/A

External source overview

PCC website

Top 

Susan G Komen: Career Catalyst Research (CCR) Grants: Pre Applications

Grant typeInternational Grant

Funding opportunity

Susan G Komen: Career Catalyst Research (CCR) Grant: Pre Applications

Scheme overview

CCR Grants provide professional development opportunities for scientists in the early stages of their career to lead a research project addressing an important question in breast cancer research, and complete a self-defined career development plan with support from a mentor committee.

CCR grants support hypothesis-driven research projects that have significant potential to:

  •  advance an understanding of breast cancer,
  • lead to reductions in breast cancer incidence and/or mortality, and
  • move toward the goal of a world without breast cancer.

Two Requests for Applications (RFA's) have been released for this mechanism:

  • CCR-Clinical Research - for clinical faculty proposing clinical research (as defined within the RFA), and
  • CCR-Basic and Translational Research - for basic or clinical faculty proposing laboratory-based biomedical research.

Funding available

Up to US$150,000 per year for up to three years

Eligibility

Applicants must:

  • Have a doctoral degree, including MD, PhD, DrPH, DO, or equivalent.
  • Currently hold a faculty appointment or have a formal offer letter at the time of application, verified by a Letter of Institutional Support.
  • Not have held any faculty appointment, including non-tenure and tenure track appointments combined, for more than a total of 6 years at the time of application, verified by a Letter of Institutional Support.

Applicants are not required to be U.S. citizens or residents.

Opening date

June 2020

Internal closing date

N/A

External closing date: Letter of Intent

 

Compliance check (RIS/GPT)

Grant Partnerships Team

External source overview

Susan G Komen website

Top   

US Department of Defense (DOD) Research Program Grants

Grant typeInternational Grant

Funding opportunity

Funding opportunities have recently been released by the US Department of Defense (DOD). These include:

Scheme overview

Submission is a two-step process requiring both:

Funding available

between $700,00 and $1.2m

Eligibility

Refer to website

Opening date

July 2019

Internal closing date

Not required until step 2 of application

External closing date

 

Compliance check (RIS/GPT)

Grant Partnerships Team

External source overview

US Grants website

Top 

Wellcome Trust - Seed Awards in Science

Grant typeGrant

Funding opportunity

Wellcome Trust - Seed Awards in Science

Scheme overview

The aim of the Seeding Drug Discovery is to develop drug-like, small molecules that will be the springboard for further research and development by the biotechnology and pharmaceutical industry in areas of unmet medical need.

Funding available

There is no set amount of funding; this will be determined by justified costs.

Eligibility

The Wellcome Trust

  • offers technology transfer funding schemes which are open to Australian researchers.
  • Funding is not limited to academic institutions and a UK collaborator is not required.
  • Calls are usually made twice a year with preliminary application deadlines in June and November. 

Opening date

There are two rounds opening in January and April annually

Internal closing date

N/A

External closing date

Round 1: March 2020 - Round 2: July 2020

Compliance check (RIS/GPT)

N/A 

External source overview

Wellcome Trust website: Seeding Drug Discovery

Top 

Wellcome Trust - Pathfinder Award Scheme

Grant typeGrant

Funding opportunity

Wellcome Trust - Pathfinder Award Scheme

Scheme overview

The diagnosis, prevention and treatment of orphan and neglected diseases present an unmet medical need. To address the obstacles of product development research in these areas, the Wellcome Trust is seeking to fund pilot studies to develop assets and de-risk future development.

The Pathfinder Award Scheme is intended to kick-start pilot projects that have significant potential to help develop innovative new products in these disease areas. In the scheme, an academic lead (or a lead from a not-for-profit entity) will build on or establish a partnership with a company that has specialist knowledge and access to technologies to facilitate the development of a specific product.

Projects covering any aspect of product development for neglected and orphan diseases could be considered provided the company partner provides a matching funding contribution. Typically, an eligible partnership would be with an established company who can provide evidence that it has previously developed and subsequently taken a product to market.

Funding available

£100,000 for 18 months maximum Evidence of a matching funding contribution from the company partner will be expected.

Eligibility

Projects must address an unmet need in a neglected or orphan disease. The proposed project should aim to build credible assets that would be competitive to attract further investment by the company or funding schemes provided by Technology Transfer.

The concept to be tested must be at a stage where an application for a full award through Technology Transfer's current funding schemes is unlikely to succeed because it is too early; however, it must not be so early that at the end of the pilot work it would still be premature to compete for full funding under such schemes.

There should be a strong project focus (not a pipeline or undefined future scope of work).

The scheme will not support:

  • target validation
  • blue skies or curiosity-driven research
  • late-stage programmes already developed to a point where funding from commercial or venture sources could readily be sought to complete the pathway to market.

Opening date

There are two rounds opening in May and August annually. 2 deadlines per year subject to funding availability.

Internal closing date

Round 1: Closed Round 2: Closed

External closing date

Round 1: Closed Round 2: Closed

Compliance check (RIS/GPT)

Grant Partnerships Team

External source overview

Wellcome Trust website: Pathfinder Awards

Top                      

Wellcome Trust: Collaborative Awards in Science

Grant typeGrant

Funding opportunity

Wellcome Trust - Collaborative Awards in Science

Scheme overview

The Wellcome Trust has launched a new Collaborative Award in Science scheme, supporting groups of researchers who are pursuing scientific problems. Collaborative Awards provide flexible support to excellent groups of independent researchers with outstanding track records. Proposals must address important scientific problems that can only be achieved through a collaborative team effort.

Awards will normally be for up to five years. They provide funding for the direct costs of carrying out the research and may include:

  • research expenses, including research assistance, animals, equipment and fieldwork costs
  • travel and subsistence
  • overseas allowances, where appropriate
  • research management and support costs, where applicable.
  • Provision for public engagement costs to communicate research to the public

Funding available

Up to £4 million

Eligibility

Note that, for Australia-resident researchers, applications for this scheme will normally be through an eligible UK organisation and be led by a UK-based collaborator.

The eligibility criteria for Principal applicants apply:

  • hold an academic or research post (or equivalent)
  • have at least five years' postdoctoral (or equivalent) research experience. Individuals who hold an established lectureship or a well-recognised fellowship (e.g. Royal Society University Research Fellowship) but who have less than five years' postdoctoral experience are also eligible. Other researchers with less than five years' experience should contact the Grants Information Desk for further advice.
  • be in receipt of salary funding for the duration of the grant requested or, if this is not in place, have a position that is underwritten by their employing institution for the duration of the grant.

Opening date

January, April and August annually

Internal closing date:

N/A

External closing date: Preliminary application

20 August 2019 

External closing date: Full Applications by invitation only

12 November 2019

Compliance check (RIS/GPT)

N/A

External source overview

Wellcome Trust website

 

Top